Clinical Trials Resource Center
View By:Year | Company | Conditions | Therapeutic Areas | Drug Names
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995
The following database contains a listing of drugs approved by the Food and Drug Administration (FDA) for sale
in the United States. Drug information typically includes the drug name, approval status, indication of use, and
clinical trial results.
Review descriptions for our medical therapeutic area list to help
assist in your search.
Join our Drug Research Updates group on LinkedIn!
Prestalia (perindopril arginine and amlodipine besylate); Symplmed Pharmaceuticals;
For the treatment of hypertension, Approved January 2015
Savaysa (edoxaban); Daiichi Sankyo;
For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015
Cosentyx (secukinumab); Novartis;
For the treatment of plaque psoriasis, Approved January 2015
Natpara (parathyroid hormone) ; NPS Pharmaceuticals;
For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015
Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb;
For the treatment of HIV-1 infection, Approved January 2015
Bexsero (Meningococcal Group B Vaccine); Novartis;
For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015
Rytary (carbidopa and levodopa) extended-release capsules; Impax Labs;
For the treatment of Parkinson's disease, Approved January 2015